Mariya Rozenblit

Dr. Mariya Rozenblit is an Assistant Professor of Medicine at Yale School of Medicine specializing in Medical Oncology. She holds appointments at Yale Cancer Center and the Center for Breast Cancer, where she leads translational research initiatives. Her clinical practice focuses exclusively on breast cancer management, from ductal carcinoma in situ to metastatic disease.

She completed her medical education at Icahn School of Medicine (MD 2015), internal medicine residency at NYU Langone Medical Center (2018), and medical oncology fellowship at Yale. Her research program investigates:

• Biomarker-driven clinical trial design
• Genomic alterations preceding breast cancer development
• Oligometastatic disease biology
• Age-specific molecular differences in breast cancer
• Immunotherapy biomarkers in early-stage disease

Recent publications (2022-2025) demonstrate consistent focus on breast cancer genomics and precision oncology. Over 80% of her 15 most recent articles examine molecular biomarkers, with particular emphasis on:

• Homologous recombination deficiency signatures
• HER2-low characterization
• ctDNA analysis techniques
• Germline mutation patterns in young patients
• Epigenetic aging markers

Honors include:

• ASCO Conquer Cancer Young Investigator Award (2020)
• Susan G. Komen Career Catalyst Grant (2022)

She currently serves as sub-investigator on multiple clinical trials evaluating novel therapeutic approaches for breast cancer. Her research group collaborates extensively with Yale's Genomics, Genetics, and Epigenetics Program.